跳至主要内容
临床试验/ACTRN12613000621718
ACTRN12613000621718尚未招募未知

In patients with an acute exacerbation of COPD, do positive expiratory pressure (PEP) devices, compared to standard physiotherapy exercises, reduce patient reported symptoms of breathlessness, cough and sputum.

Brigitte Eastwood0 个研究点目标入组 75 人开始时间: 2013年5月30日最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
75

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Diagnosis of mild, moderate or severe COPD (as defined by spirometry) based on the Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines
  • 18 years or over.
  • Admitted to Middlemore Hospital medical wards.
  • Exacerbation with reported sputum based on GOLD definition from COPDx Guidelines (An exacerbation is an event in the natural course of the disease characterised by a change in the patient’s baseline dyspnoea, cough, and/or sputum that is beyond normal day-to-day variations, is acute in onset, and may warrant a change in regular medication in a patient with underlying COPD)
  • English speaking and reading
  • Consent to research

排除标准

  • Non English speaking or reading
  • Unable to complete questionnaires or actively participate in treatment for any other reason (medical, physical, psychological)
  • Any previous PEP use at home
  • Receiving Bilevel positive airway pressure (BiPAP) treatment (as already receiving a form of positive pressure)
  • Any contraindications to PEP - large bullous disease, undrained pneumothorax
  • Any contraindications to airway clearance techniques, namely frank haemoptysis
  • Any patients previously recruited into this trial on any other admission

研究者

发起方
Brigitte Eastwood

相似试验